Carlo Colosimo Selected Research

Injections

6/2021	Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
1/2021	Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity.
1/2020	Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.
12/2019	How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.
2/2015	Factors influencing secondary non-response to botulinum toxin type A injections in cervical dystonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlo Colosimo Research Topics

Disease

14	Parkinson Disease (Parkinson's Disease) 03/2022 - 11/2003
12	Torticollis (Wryneck) 06/2021 - 03/2011
8	Movement Disorders (Movement Disorder) 02/2023 - 02/2009
5	Dystonia (Limb Dystonia) 01/2021 - 03/2010
4	Essential Tremor (Essential Tremors) 04/2017 - 12/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2023 - 01/2016
3	Parkinsonian Disorders (Parkinsonism) 01/2021 - 11/2003
3	Paresis (Hemiparesis) 01/2020 - 04/2017
3	Camptocormia 01/2020 - 01/2009
3	Tremor (Tremors) 01/2020 - 12/2015
3	Muscle Spasticity (Spastic) 01/2020 - 04/2017
3	Dyskinesias (Dyskinesia) 07/2014 - 11/2003
2	Tauopathies 10/2023 - 01/2019
2	Orthostatic Hypotension (Postural Hypotension) 09/2023 - 04/2016
2	Neoplasms (Cancer) 05/2023 - 12/2021
2	Nervous System Diseases (Neurological Disorders) 11/2019 - 10/2013
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 07/2017 - 01/2016
2	Dystonic Disorders (Writer's Cramp) 04/2017 - 11/2012
2	Dementia (Dementias) 01/2016 - 07/2014
2	Multiple System Atrophy 01/2012 - 02/2009
1	Chronic Progressive Multiple Sclerosis 12/2023
1	Multiple Sclerosis 12/2023
1	Synucleinopathies 10/2023
1	Cysts 10/2023
1	Proteostasis Deficiencies 10/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2023
1	Type 2 Diabetes Mellitus (MODY) 03/2022
1	Diabetes Mellitus 03/2022
1	Brain Neoplasms (Brain Tumor) 12/2021
1	Muscle Rigidity 01/2020
1	Hypokinesia (Bradykinesia) 01/2020
1	Food Addiction 01/2018
1	Gambling (Pathological Gambling) 01/2018
1	Atrophy 07/2017
1	Weight Loss (Weight Reduction) 04/2017
1	Sleepiness 01/2017
1	Fatigue 01/2017
1	Headache (Headaches) 01/2017
1	Nausea 01/2017
1	Disease Progression 01/2017
1	Corticobasal Degeneration 01/2016
1	Constipation 12/2015
1	Huntington Disease (Huntington's Disease) 04/2015
1	Blepharospasm 11/2012
1	Cognitive Dysfunction 06/2012
1	Autonomic Nervous System Diseases (Dysautonomia) 11/2010
1	Nocturia 07/2010
1	Ataxia (Dyssynergia) 06/2008

Drug/Important Bio-Agent (IBA)

12	Botulinum Toxins (Botulinum Toxin)IBA 06/2021 - 01/2009
11	Levodopa (L Dopa)FDA LinkGeneric 09/2023 - 11/2003
10	Type A Botulinum Toxins (Botox)FDA Link 01/2020 - 03/2011
6	incobotulinumtoxinA FDA Link 01/2020 - 11/2012
5	Apomorphine FDA Link 07/2021 - 11/2003
4	Dopamine Agonists (Dopamine Agonist)IBA 03/2022 - 11/2003
3	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2017
3	tau Proteins (tau Protein)IBA 10/2023 - 01/2016
3	Surface Antigens (Surface Antigen)IBA 05/2023 - 09/2019
3	AntibodiesIBA 05/2023 - 09/2019
3	Dopamine (Intropin)FDA LinkGeneric 03/2022 - 07/2017
2	Immune Checkpoint InhibitorsIBA 05/2023 - 12/2021
2	Carbidopa (Lodosyn)FDA LinkGeneric 07/2021 - 01/2021
1	Amyloid (Amyloid Fibrils)IBA 10/2023
1	Protein Isoforms (Isoforms)IBA 10/2023
1	ClusterinIBA 10/2023
1	SynucleinsIBA 10/2023
1	Chromogranin AIBA 10/2023
1	Cystatin CIBA 10/2023
1	Amyloid beta-PeptidesIBA 10/2023
1	TESIBA 09/2023
1	AntigensIBA 05/2023
1	Insulin (Novolin)FDA Link 03/2022
1	Bromocriptine (Parlodel)FDA LinkGeneric 03/2022
1	ANNA-2 antibodyIBA 01/2021
1	abobotulinumtoxinA FDA Link 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2017
1	LigandsIBA 07/2017
1	Topiramate (Topamax)FDA LinkGeneric 04/2017
1	Monoamine Oxidase (MAO)IBA 01/2017
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2017
1	Catechol O-Methyltransferase InhibitorsIBA 01/2017
1	Pregabalin (Lyrica)FDA Link 10/2016
1	Antihypertensive Agents (Antihypertensives)IBA 04/2016
1	ProgranulinsIBA 01/2016
1	alpha-SynucleinIBA 01/2016
1	Alprazolam (Xanax)FDA LinkGeneric 12/2015
1	NucleotidesIBA 04/2015
1	Nicotine FDA Link 01/2012
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2009

Therapy/Procedure

13	Therapeutics 02/2023 - 11/2003
5	Injections 06/2021 - 02/2015
3	Deep Brain Stimulation 07/2021 - 01/2012
2	Immunotherapy 12/2021 - 09/2019
1	Transplantation 12/2023
1	Contraindications 07/2014
1	Subcutaneous Infusions 07/2014
1	Neurological Rehabilitation 10/2013
1	Activities of Daily Living (ADL) 07/2010
1	Drug Therapy (Chemotherapy) 07/2010